MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test may tell who needs extra immunotherapy after bladder cancer surgery
Disease control Recruiting nowThis large trial is testing whether a blood test that looks for tumor DNA can help decide who needs immunotherapy after surgery for muscle-invasive urothelial cancer. About 992 participants will be assigned to different treatment plans based on their blood test results. The goal …
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug cocktail aims to save bladders in cancer fight
Disease control Recruiting nowThis phase 2 trial tests two drugs, enfortumab vedotin and pembrolizumab, in 47 people with muscle-invasive bladder cancer. The goal is to see if the combination can eliminate the cancer so patients can keep their bladder instead of having it surgically removed. After three cycle…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Matthew Galsky • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New combo therapy aims to spare bladders in cancer patients
Disease control Recruiting nowThis phase II trial is testing whether giving the immunotherapy drug pembrolizumab along with radiation therapy after chemotherapy can help patients with muscle invasive bladder cancer avoid bladder removal surgery. About 111 participants who responded well to initial chemotherap…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could fewer radiation sessions be just as effective for bladder cancer?
Disease control Recruiting nowThis study compares two radiation schedules for people with muscle-invasive bladder cancer who also receive chemotherapy. One group gets the usual number of radiation treatments, while the other gets fewer, higher-dose sessions. The goal is to see if the shorter course works just…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Simple DNA test could reveal hidden bladder cancer before surgery
Diagnosis Recruiting nowThis study is testing whether a combined blood and urine DNA test can accurately detect muscle-invasive bladder cancer in patients scheduled for bladder removal surgery. Researchers will compare the test results with the actual findings from surgery. The goal is to see if this no…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Sponsor: Fox Chase Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
A simple blood draw could detect bladder Cancer's return — a trial puts it to the test
Knowledge-focused Recruiting nowThis study tests whether a blood test that looks for tumor DNA can detect if bladder cancer has come back after treatment. Researchers will collect blood, urine, and tissue samples from 100 people with muscle-invasive bladder cancer to see how well the test matches standard metho…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC